Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells. [electronic resource]
Producer: 20141028Description: 3356-75 p. digitalISSN:- 1420-3049
- ADP-ribosyl Cyclase 1 -- metabolism
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters -- genetics
- Animals
- Antigens, CD34 -- metabolism
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Drug Resistance, Multiple -- drug effects
- Drug Synergism
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Gene Expression
- Humans
- Inhibitory Concentration 50
- Leukemia
- Mice
- Neoplasm Proteins -- genetics
- Neoplastic Stem Cells -- drug effects
- Pyrimidines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.